NexImmune, Inc. (NEXI)
OTCMKTS · Delayed Price · Currency is USD
0.0100
+0.0099 (9,900.00%)
At close: Dec 10, 2025
NexImmune Market Cap
NexImmune has a market cap or net worth of $13.95 thousand as of December 16, 2025. Its market cap has decreased by -99.81% in one year.
Market Cap
13.95K
Enterprise Value
-2.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since February 12, 2021, NexImmune's market cap has decreased from 545.88M to 13.95K, a decrease of -100.00%. That is a compound annual growth rate of -88.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 13.95K | -91.31% |
| Dec 31, 2024 | 160.46K | -93.17% |
| Dec 29, 2023 | 2.35M | -62.95% |
| Dec 30, 2022 | 6.34M | -93.94% |
| Dec 31, 2021 | 104.70M | -80.82% |
| Feb 12, 2021 | 545.88M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Glass House Brands | 789.81M |
| Elite Pharmaceuticals | 534.83M |
| CytoDyn | 398.68M |
| Northwest Biotherapeutics | 396.23M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 296.16M |
| Nika Pharmaceuticals | 285.90M |